Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
482.60    1.60 (0.33%)
Bid:
482.40
Ask:
482.80
Spread: 0.40 (0.083%)
Market Cap: £1.31b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Trading Update

27 Nov 2012 07:00

RNS Number : 0473S
Chemring Group PLC
27 November 2012
 



 

 

FOR IMMEDIATE RELEASE 27 November 2012

 

CHEMRING GROUP PLC

 

 Trading Update

 

 

Chemring Group PLC ("Chemring" or "the Group") today provides an update on trading having entered the close period in respect of its preliminary results for the financial year ended 31 October 2012.

 

Trading

 

The Group's performance during 2012 was extremely disappointing. Chemring's operational performance has been weak, and management of investors' expectations over the past year has also been poor. In part, this resulted from a failure to anticipate the likely impact of the changing market dynamics on the Group's businesses, but also reflected failures in performance at several of our businesses.

 

Expectations for the Group's trading performance for the financial year ended 31 October 2012 remain in line with the trading update issued on 1 November 2012. The following further detail is subject to final audit.

 

Trading in the final quarter was impacted by the issues set out in the 1 November 2012 trading statement that principally affected the Countermeasures and Munitions business segments. As a result, turnover for the financial year ended 31 October 2012 is expected to be approximately £740 million (2011: £725 million).

 

The year end order book of approximately £760 million compares to £878.3 million at the prior year end.

 

Financial position

 

There was a significant operating cash inflow in the final quarter that resulted in net debt at the year end of approximately £250 million. (2011: £262.7 million).

 

Market conditions

 

Defence spending in the US, UK and Europe is expected to remain under significant pressure.

 

The US defence market remains vulnerable to ongoing budget uncertainties, particularly around sequestration and the impact of a six month continuing resolution from 1 October 2012. The threat of sequestration continues to have a negative impact on customer behaviour, and there is a lack of clarity about defence expenditure in the medium term. As a result, we are seeing delays in the procurement process whilst customers await greater visibility and certainty as to their future budgets.

 

The UK MoD's review of its procurement process continues to result in delays to the start of new programmes and reduced funding for existing ones whilst, in Europe, ongoing deficit reduction programmes are exerting downward pressure on defence spending, leading to uncertainty in the procurement process and delayed programme implementation.

 

Chemring's non-NATO markets continue to offer opportunities, although order intake remains subject to the granting of export licence approval, which is proving more difficult to achieve in some markets.

 

Outlook

 

The wider market backdrop is likely to remain challenging. Chemring needs to adapt and better equip itself in order to meet these challenges.

 

Mark Papworth joined Chemring as Chief Executive Officer on 5 November 2012, and brings significant experience of delivering performance improvement and implementation of strategic change in the manufacturing, technology and service sectors. He will present his initial views on Chemring and his operational priorities at the Group's preliminary results which are expected to be announced on 24 January 2013.

 

 

- Ends -

 

 

A conference call for analysts and investors will be held at 08.30 GMT today. Dial-in details are as follows:

 

Participant dial in: +44 (0)20 3140 0668 (toll) / 0800 368 1950 (toll free)

PIN: 475152#.

 

A playback facility will be available for 30 days. Dial-in details are 020 3140 0698/0800 368 1890

PIN: 388348#

 

 

For further information:

 

Chemring Group PLC:

 

Rupert Pittman Director of Communications 01489 881 880

& Investor Relations rupertp@chemring.co.uk

 

MHP Communications:

 

Andrew Jaques / John Olsen / James White 0203 128 8100

chemringplc@mhpc.com

 

Cautionary statement: 

 

This announcement contains forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

 

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

 

Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBKADNOBDDCDB
Date   Source Headline
20th Jan 201711:08 amRNSDirector/PDMR Shareholding
20th Jan 201711:05 amRNSDirector/PDMR Shareholding
19th Jan 20172:13 pmRNSDirector/PDMR Shareholding
19th Jan 20177:00 amRNSFinal Results
3rd Jan 201710:00 amRNSTotal Voting Rights
13th Dec 20167:00 amRNSDirectorate Change
1st Dec 20169:34 amRNSTotal Voting Rights
21st Nov 20167:00 amRNSPOST-CLOSE STATEMENT
1st Nov 20169:40 amRNSTotal Voting Rights
3rd Oct 201610:10 amRNSTotal Voting Rights
29th Sep 201610:53 amRNSContract Win
1st Sep 20169:05 amRNSTotal Voting Rights
31st Aug 20167:00 amRNSQ3 UPDATE
25th Aug 20163:32 pmRNSHolding(s) in Company
17th Aug 201611:31 amRNSHolding(s) in Company
12th Aug 20169:34 amRNSDirector/PDMR Shareholding
3rd Aug 20169:43 amRNSTotal Voting Rights
28th Jul 201612:29 pmRNSDirector/PDMR Shareholding
22nd Jul 201610:07 amRNSHolding(s) in Company
21st Jul 20167:00 amRNSContract Win
18th Jul 20163:41 pmRNSHolding(s) in Company
4th Jul 20162:22 pmRNSHolding(s) in Company
1st Jul 20169:50 amRNSTotal Voting Rights
29th Jun 20167:00 amRNSDirectorate Change
28th Jun 20169:20 amRNSHolding(s) in Company
23rd Jun 201611:21 amRNSHolding(s) in Company
22nd Jun 20169:15 amRNSDirector/PDMR Shareholding
21st Jun 20161:12 pmRNSDirector/PDMR Shareholding
21st Jun 20167:00 amRNSINTERIM RESULTS
20th Jun 20162:39 pmRNSBlock listing Interim Review
20th Jun 20162:37 pmRNSBlock listing Interim Review
1st Jun 201611:01 amRNSTotal Voting Rights
17th May 20167:00 amRNSDirectorate Change
10th May 20164:20 pmRNSDirector/PDMR Shareholding
5th May 20167:00 amRNSCompletion of Acquisition
3rd May 201610:08 amRNSTotal Voting Rights
27th Apr 20162:13 pmRNSDirectorate Change
25th Apr 20169:52 amRNSDirector/PDMR Shareholding
19th Apr 20167:00 amRNSAPPOINTMENT OF CHAIRMAN-DESIGNATE
6th Apr 20164:15 pmRNSDirector/PDMR Shareholding
4th Apr 20167:00 amRNSContract Update
1st Apr 20169:48 amRNSTotal Voting Rights
24th Mar 201610:36 amRNSHolding(s) in Company
21st Mar 20162:05 pmRNSResult of AGM
21st Mar 201611:00 amRNSAGM Trading Update
8th Mar 20162:36 pmRNSDirector/PDMR Shareholding
7th Mar 20167:00 amRNSAPPOINTMENT OF NON-EXECUTIVE DIRECTOR
1st Mar 20165:26 pmRNSCorrection Re Holding in Company
1st Mar 20161:24 pmRNSTotal Voting Rights
26th Feb 201610:23 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.